Status:
COMPLETED
How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
Lead Sponsor:
The Royal Bournemouth Hospital
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The study is aimed at Type 2 Diabetics who are taking Metformin, but whose Diabetes remains poorly controlled. There are two additional medications already in use, Glimepiride and Sitagliptin will be ...
Eligibility Criteria
Inclusion
- Diabetes Mellitus
- Currently on Metformin but poor glycaemic control,
Exclusion
- Under 18 years of age
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00747383
Start Date
September 1 2008
End Date
September 1 2010
Last Update
December 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Bournemouth Hospital
Bournemouth, Dorset, United Kingdom, BH7 7DW